Luteolin

TargetMol
Product Code: TAR-T1027
Supplier: TargetMol
CodeSizePrice
TAR-T1027-10mg10mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1027-1mL1 mL * 10 mM (in DMSO)£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1027-50mg50mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1027-100mg100mg£116.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1027-200mg200mg£144.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Luteolin is a naturally occurring flavonoid. The flavonoids are polyphenolic compounds found as integral components of the human diet. In vitro work has concentrated on the direct and indirect actions of flavonoids on tumor cells, and has found a variety of anticancer effects such as cell growth and kinase activity inhibition, apoptosis induction, suppression of the secretion of matrix metalloproteinases and of tumor invasive behavior. Furthermore, some studies have reported the impairment of in vivo angiogenesis by dietary flavonoids. Experimental animal studies indicate that certain dietary flavonoids possess antitumoral activity.
CAS:
491-70-3
Formula:
C15H10O6
Molecular Weight:
286.239
Pathway:
Autophagy; Immunology/Inflammation; Metabolism; Apoptosis
Purity:
0.98
SMILES:
Oc1cc(O)c2c(c1)oc(cc2=O)-c1ccc(O)c(O)c1
Target:
Apoptosis; Nrf2; Endogenous Metabolite; PDE; Autophagy

References

1. Yu MC, et al. Eur J Pharmacol, 2010, 627(1-3), 269-275. 2. Xagorari A, et al. J Pharmacol Exp Ther, 2001, 296(1), 181-187. 3. Hwang Y H, Jang S A, Kim T, et al. Anti-osteoporotic and Anti-adipogenic Effects of Rhus chinensis Nutgalls in Ovariectomized Mice Fed with a High-fat Diet[J]. Planta medica. 2019. 4. Dong J, Xu O, Wang J, et al.?. Luteolin ameliorates inflammation and Th1/Th2 imbalance via regulating the TLR4/NF-?B pathway in allergic rhinitis rats[J]. Immunopharmacology and Immunotoxicology. 2021: 1-9 5. Ding X, Zheng L, Yang B, et al. Luteolin Attenuates Atherosclerosis Via Modulating Signal Transducer And Activator Of Transcription 3-Mediated Inflammatory Response[J]. Drug Des Devel Ther. 2019, 13: 3899. 6. Yang Y, Tan X, Xu J, et al. Luteolin alleviates neuroinflammation via downregulating the TLR4/TRAF6/NF-?B pathway after intracerebral hemorrhage[J]. Biomedicine & pharmacotherapy. 2020, 126: 110044. 7. Tan X, Yang Y, Xu J, et al. Luteolin Exerts Neuroprotection via Modulation of the p62/Keap1/Nrf2 Pathway in Intracerebral Hemorrhage[J]. Frontiers in Pharmacology. 2020, 10: 1551.